Targeting molecular scaffolds for the treatment of obesity and metabolic disease

靶向分子支架治疗肥胖和代谢疾病

• 批准号: 356009
• 负责人: Lim Gareth E
• 金额: $ 50.99万
• 依托单位: Centre hospitalier de l'Universit de Montral (CHUM)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2021-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=356009&lang=en
• 关键词: 14-3-3; Adipocyte; Adipogenesis; Differentiation; Metabolism; Obesity; Progenitor; Proteomics; Scaffold

As a risk factor for diabetes, cardiovascular disease, and cancer, obesity has been steadily increasing in society at alarming rates. Approximately 25% of Canadians are either over-weight or obese. Anti-obesity therapies have varying degrees of effectiven

肥胖作为糖尿病、心血管疾病和癌症的风险因素，在社会上一直在以惊人的速度稳步增长。大约25%的加拿大人超重或肥胖。减肥疗法有不同程度的效果